| 000 | 01635 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250517151009.0 | ||
| 264 | 0 | _c20180509 | |
| 008 | 201805s 0 0 eng d | ||
| 022 | _a1365-2125 | ||
| 024 | 7 |
_a10.1111/bcp.13307 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKannangara, Diluk R W | |
| 245 | 0 | 0 |
_aIndividualising the dose of allopurinol in patients with gout. _h[electronic resource] |
| 260 |
_bBritish journal of clinical pharmacology _cSep 2017 |
||
| 300 |
_a2015-2026 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study; Observational Study; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAllopurinol _xpharmacokinetics |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Dosage Calculations |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGout _xblood |
| 650 | 0 | 4 |
_aGout Suppressants _xpharmacokinetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aModels, Biological |
| 650 | 0 | 4 |
_aOxypurinol _xblood |
| 650 | 0 | 4 |
_aUric Acid _xblood |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aGraham, Garry G | |
| 700 | 1 | _aWright, Daniel F B | |
| 700 | 1 | _aStocker, Sophie L | |
| 700 | 1 | _aPortek, Ian | |
| 700 | 1 | _aPile, Kevin D | |
| 700 | 1 | _aBarclay, Murray L | |
| 700 | 1 | _aWilliams, Kenneth M | |
| 700 | 1 | _aStamp, Lisa K | |
| 700 | 1 | _aDay, Richard O | |
| 773 | 0 |
_tBritish journal of clinical pharmacology _gvol. 83 _gno. 9 _gp. 2015-2026 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/bcp.13307 _zAvailable from publisher's website |
| 999 |
_c27088932 _d27088932 |
||